Insider Selling: Adtalem Global Education (NYSE:CVSA) Insider Sells 2,000 Shares of Stock

Adtalem Global Education Inc. (NYSE:CVSA) insider Karen Sue Cox sold 2,000 shares of the business’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $124.50, for a total value of $249,000.00. Following the completion of the transaction, the insider directly owned 31,596 shares in the company, valued at approximately $3,933,702. This represents a 5.95% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Down 1.5%

CVSA stock traded down $1.96 during midday trading on Tuesday, hitting $128.28. The company’s stock had a trading volume of 239,676 shares, compared to its average volume of 392,864. The company’s 50-day moving average is $111.84. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.36. Adtalem Global Education Inc. has a 1 year low of $86.97 and a 1 year high of $156.26. The stock has a market cap of $4.37 billion, a PE ratio of 19.98, a price-to-earnings-growth ratio of 1.11 and a beta of 0.63.

Adtalem Global Education (NYSE:CVSA) last posted its quarterly earnings data on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, topping the consensus estimate of $1.73 by $0.25. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The business had revenue of $487.03 million for the quarter. During the same period in the prior year, the firm posted $1.92 EPS. The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, equities analysts forecast that Adtalem Global Education Inc. will post 8.05 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on CVSA shares. Zacks Research cut Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Wall Street Zen lowered Adtalem Global Education from a “buy” rating to a “hold” rating in a research note on Saturday. Truist Financial boosted their target price on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday. Weiss Ratings assumed coverage on Adtalem Global Education in a research note on Wednesday, February 25th. They issued a “hold (c+)” rating on the stock. Finally, Barrington Research restated an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a research note on Friday, April 17th. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Adtalem Global Education presently has a consensus rating of “Moderate Buy” and an average target price of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.